Atricure Inc
Company Overview
AtriCure, Inc. is a medical device company that develops, manufactures, and sells innovative products designed to treat atrial fibrillation (Afib) and related conditions. The company specializes in surgical ablation systems, left atrial appendage management devices, and products for pain management. Their primary focus is on developing solutions for the treatment of Afib, a serious heart condition affecting millions of people worldwide.
The company's product portfolio includes the Isolator Synergy Ablation System, AtriClip Left Atrial Appendage Exclusion System, and cryoSPHERE cryoablation probe, among others. These devices are used in both open-heart and minimally invasive surgical procedures.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $115.91m | $124.98m | - | $1.67m | 0.00% | 1.33% |
| June 30, 2024 | $116.27m | $125.05m | - | $1.61m | 0.00% | 1.29% |
| March 31, 2024 | $108.85m | $122.81m | - | $3.04m | 0.00% | 2.47% |
Company Impact
Help us evaluate Atricure Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.